MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
+31.63%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$91M
AUM Growth
+$91M
(+18%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
98.57%
Holding
11
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wave Life Sciences
WVE
$1.53B
| $50.5M | 55.55% | 6,164,548 | – | – |
|
2
Invivyd
IVVD
$204M
| $9.43M | 10.37% | 9,248,250 | – | – |
|
3
Rocket Pharmaceuticals
RCKT
$354M
| $7.12M | 7.83% | 385,680 | – | – |
|
4
Fractyl Health
GUTS
$68.8M
| $4.7M | 5.16% | 1,856,117 | – | – |
|
5
TG Therapeutics
TGTX
$4.65B
| $3.78M | 4.15% | 161,600 | – | – |
|
|
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
| $3.54M | 3.89% | 110,400 | – | – |
|
|
SLN
7
Silence Therapeutics
SLN
$227M
| $3.37M | 3.7% | 185,100 | – | – |
|
8
BridgeBio Pharma
BBIO
$9.89B
| $3.09M | 3.39% | 121,200 | – | – |
|
9
Curis
CRIS
$20.9M
| $2.27M | 2.5% | 421,951 | – | – |
|
10
ProQR Therapeutics
PRQR
$237M
| $1.86M | 2.04% | 1,019,498 | – | – |
|
11
Arrowhead Research
ARWR
$3.05B
| $1.31M | 1.43% | 67,400 | – | – |
|